SA
BNTX logo
BioNTech SE(BNTX)
Closing price · checked 11:58 AM ETAbout this dataData status
$80.96▼-0.42 (-0.52%)
Extended:$80.92-0.04 (-0.06%)· 11:58 AM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

BioNTech SE (BNTX)

Total Non-Current Liabilities

€629.30M

Quarterly · Period ending: · EUR

BNTX logo

BNTX Total Non-Current Liabilities

Latest reported€621.84M EUR
BNTX FY Total Non-Current Liabilities · EUR (€301.47M → €621.84M)
Powered by
High-resolution chart · PNG

What is total non-current liabilities?

Long-term obligations due beyond one year.

BNTX total non-current liabilities history

Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

BioNTech SE Total Non-Current Liabilities — Annual fiscal periods (EUR)
Period endingTotal Non-Current Liabilities (EUR)Change
621,835,230+4.44%
595,400,000−13.70%
689,900,000+152.80%
272,900,000−40.09%
455,500,000+33.66%
340,800,000+105.29%
166,013,000−36.12%
259,865,000−1.71%
264,375,000−12.30%
301,465,000—

Frequently asked questions: BNTX total non-current liabilities

What is BioNTech SE (BNTX)'s current total non-current liabilities?

BioNTech SE (BNTX)'s latest reported total non-current liabilities (Quarterly) is €629.30M as of Sep 30, 2026. Long-term obligations due beyond one year.

How much historical total non-current liabilities data is available for BNTX?

Stock Alarm Pro provides 10 dated annual fiscal periods observations for BioNTech SE (BNTX)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare BNTX's total non-current liabilities to peers or set an alert?

You can open BNTX's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on BNTX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.